Supplements

MotilPro vs Motility Activator: Prokinetic Supplements Compared

April 13, 202610 min readBy GLP1Gut Team
MotilProMotility ActivatorprokineticSIBOginger

Prokinetics are arguably the most underused tool in SIBO management. Antimicrobial treatment — whether rifaximin, herbal protocols, or elemental diet — addresses the bacterial overgrowth itself. But if the underlying motility dysfunction that allowed bacteria to accumulate in the first place isn't corrected, SIBO comes back. The migrating motor complex (MMC), the electrical sweep that clears bacteria from the small intestine between meals, is impaired in a significant proportion of SIBO patients. Prokinetic agents restore this function. While pharmaceutical prokinetics like prucalopride and low-dose naltrexone exist, many patients and practitioners start with nutraceutical prokinetics. The three most discussed supplements in this category are MotilPro (Pure Encapsulations), Motility Activator (Integrative Therapeutics), and Prokine (Microbiome Labs). Here's how they compare.

Why Prokinetic Supplements Matter for SIBO Prevention

The MMC is a series of coordinated muscular contractions that move through the stomach and small intestine roughly every 90-120 minutes during fasting. Its primary purpose is housekeeping: sweeping undigested food residue, sloughed cells, and bacteria from the small intestine into the colon. In healthy individuals, this process limits bacterial populations in the small bowel to fewer than 10,000 colony-forming units per milliliter.

In SIBO patients, MMC function is frequently impaired — either from post-infectious autoimmune damage (anti-vinculin antibodies targeting the MMC's pacemaker cells), structural issues (adhesions, strictures), dysautonomia, hypothyroidism, or chronic opioid use. Without a functioning MMC, bacteria repopulate the small intestine within weeks of antimicrobial treatment. This is why the SIBO recurrence rate without prokinetic support is estimated at 40-80% within the first year. Prokinetic therapy — started during or immediately after antimicrobial treatment — is the most evidence-informed strategy for reducing this recurrence.

â„šī¸Post-infectious IBS and SIBO caused by food poisoning (Campylobacter, Salmonella, E. coli 0157) involve autoimmune damage to the ICC (interstitial cells of Cajal) — the pacemaker cells that drive the MMC. Anti-vinculin and anti-CdtB antibodies can now be measured with the ibs-smart blood test. If your SIBO started after a bout of food poisoning or traveler's diarrhea, this autoimmune mechanism may be driving your recurrence, and prokinetic support becomes especially important.

MotilPro (Pure Encapsulations): Ingredient Analysis

MotilPro combines three active ingredients: ginger root extract (500 mg), 5-hydroxytryptophan or 5-HTP (50 mg), and acetyl-L-carnitine (500 mg). This is the only one of the three products that includes 5-HTP, which makes it the most unique formulation.

MotilPro ingredient evidence:

  • Ginger (Zingiber officinale, 500 mg): Ginger's prokinetic effects are well-documented. It stimulates gastric motility by activating 5-HT4 receptors and muscarinic M3 receptors, and accelerates gastric emptying in multiple RCTs in both healthy subjects and gastroparesis patients. A 2008 RCT found ginger accelerated gastric emptying by 26% compared to placebo. The 500 mg dose in MotilPro is a reasonable prokinetic dose, although some studies use up to 1200 mg.
  • 5-HTP (50 mg): 5-Hydroxytryptophan is the immediate precursor to serotonin (5-HT). Since approximately 95% of the body's serotonin is produced in the gut — primarily in enterochromaffin cells — and serotonin drives peristaltic activity via 5-HT4 receptors, providing precursor substrate theoretically supports gut motility. Clinical evidence specific to 5-HTP and gut motility is limited, but 5-HTP has good evidence for mood support, and the neurological-gut connection means it may have secondary benefits for stress-related gut dysfunction. The 50 mg dose is low (therapeutic doses for mood start at 100-200 mg), so the gut-specific effects may be modest.
  • Acetyl-L-carnitine (500 mg): ALCAR supports mitochondrial function in neurons, including the enteric nervous system. There is limited direct evidence for ALCAR specifically improving MMC function or gastric motility, but enteric neuron energy support is a logical mechanism. ALCAR has better evidence for cognitive function and peripheral neuropathy.
  • Best suited for: Patients who want the serotonin precursor pathway included, those with SIBO plus mood dysfunction or anxiety, or those who want a broader neuroenteric support formula.
  • Cost: Approximately $35-40 for 90 capsules. Standard dose is 2 capsules at bedtime on an empty stomach.

Motility Activator (Integrative Therapeutics): Ingredient Analysis

Motility Activator contains two ingredients: ginger root extract (500 mg) and artichoke leaf extract (300 mg). This simpler formula mirrors the combination studied in clinical trials for functional dyspepsia and gastroparesis and is arguably the most evidence-grounded of the three products.

Motility Activator ingredient evidence:

  • Ginger (500 mg): Same evidence base as described above. Well-established prokinetic and antiemetic effects. Works via 5-HT4 activation and muscarinic stimulation.
  • Artichoke leaf extract (Cynara scolymus, 300 mg): Artichoke has a stronger evidence base than it often receives credit for. A pivotal RCT published in Alimentary Pharmacology & Therapeutics found artichoke leaf extract significantly reduced dyspepsia symptoms and improved gastric motility in patients with functional dyspepsia. Meta-analyses confirm this benefit. The mechanism involves cholagogue (bile-stimulating) effects that improve digestion of fats, as well as direct pro-motility effects on the upper GI tract.
  • The ginger + artichoke combination has been specifically tested: A 2012 study found this combination accelerated gastric emptying more than either ingredient alone, suggesting synergy. This is the strongest evidence basis of any prokinetic supplement combination.
  • Best suited for: First-line choice for most SIBO patients seeking prokinetic support. Straightforward, well-evidenced, widely available, good tolerability.
  • Cost: Approximately $25-35 for 90 capsules. Standard dose is 2 capsules before meals or at bedtime.

Prokine (Microbiome Labs): Ingredient Analysis

Prokine from Microbiome Labs is the most comprehensive of the three, combining ginger, artichoke, and Iberogast (STW 5) in a single formula. It essentially builds on the ginger + artichoke base of Motility Activator and adds the nine-herb Iberogast liquid extract in a capsule-compatible standardized form.

Prokine ingredient evidence:

  • Ginger + Artichoke: Same evidence base as Motility Activator, in comparable doses.
  • STW 5 (Iberogast extract): As discussed in our Iberogast deep-dive article, STW 5 has the most clinical trial evidence of any herbal prokinetic formula. It works via 5-HT receptor modulation, motilin signaling, and antispasmodic effects, and has RCT evidence for functional dyspepsia superior to placebo and comparable to domperidone in some studies.
  • The combination of ginger, artichoke, and STW 5 provides the broadest prokinetic mechanism coverage of the three supplements reviewed here.
  • Consideration: Prokine inherits the greater celandine (chelidonine) hepatotoxicity concern from Iberogast. While the doses in Prokine are standardized and the chelidonine content is controlled, patients with liver concerns or those taking hepatotoxic medications should be aware of this.
  • Best suited for: Patients with more significant motility impairment who haven't responded well to simpler formulas, or those who want maximum mechanism coverage in one product.
  • Cost: Approximately $45-55 for 60 capsules (more expensive per dose). Standard dose is 2 capsules at bedtime.

Head-to-Head Comparison: Choosing the Right Prokinetic

Comparison summary across key factors:

  • Strongest clinical evidence: Motility Activator (ginger + artichoke has the most direct RCT support as a combination)
  • Broadest mechanism coverage: Prokine (adds STW 5's multiple pathways)
  • Unique serotonin precursor approach: MotilPro (only product with 5-HTP; relevant for patients with mood-gut axis issues)
  • Best value per dose: Motility Activator (~$0.56-0.78 per dose vs. $0.78-1.10 for Prokine)
  • Best for gastroparesis: All three include ginger; Prokine or Motility Activator preferred due to artichoke content
  • Liver safety concern: Prokine (STW 5 contains greater celandine); MotilPro and Motility Activator are safer choices for those with liver concerns
  • Best first choice: Motility Activator for most patients. Upgrade to Prokine if insufficient response.

💡Prokinetic supplements work best when taken at bedtime on an empty stomach, at least 2-3 hours after the last meal. The goal is to stimulate the fasting-phase MMC, which is active between meals and overnight. Taking prokinetics with meals diminishes their effect because the MMC is suppressed by the fed state. Consistency matters: prokinetic benefit builds over weeks, not days.

Combining Supplement and Prescription Prokinetics

For patients with significant MMC impairment — particularly those with post-infectious SIBO, diabetic gastroparesis, or a history of multiple relapses — nutraceutical prokinetics may not be sufficient on their own. In these cases, prescription prokinetics such as low-dose naltrexone (1.5-4.5 mg at bedtime), prucalopride (Motegrity, 1-2 mg daily), or low-dose erythromycin (50-75 mg at bedtime) may be necessary.

There is no pharmacological contraindication to combining supplement prokinetics with low-dose naltrexone or prucalopride. Many practitioners use a combination — for instance, Motility Activator at bedtime plus low-dose naltrexone — for patients with documented MMC impairment. The 5-HTP in MotilPro should be used cautiously if combined with serotonergic medications (SSRIs, SNRIs, triptans) due to theoretical serotonin syndrome risk at higher doses, though the 50 mg dose in MotilPro makes this a low risk at standard doses.

âš ī¸Do not combine 5-HTP-containing products like MotilPro with SSRIs, SNRIs, MAOIs, triptans, or tramadol without first consulting your prescriber. While the risk at 50 mg 5-HTP is low, the combination can theoretically cause serotonin syndrome — a potentially serious condition characterized by agitation, rapid heart rate, muscle rigidity, and in severe cases, hyperthermia.

**Disclaimer:** This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new treatment or making changes to your existing treatment plan.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making changes to your diet, treatment, or health regimen. GLP1Gut is a tracking tool, not a medical device.

Figure Out What's Actually Triggering You

An AI-powered meal and symptom tracker that connects what you eat to how you feel, built specifically for people on GLP-1 medications experiencing digestive side effects.